Results 11 to 20 of about 22,913 (185)
Letrozole for Female Infertility [PDF]
Frontiers in Endocrinology, 2021 Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the estrogen biosynthetic pathway, has been used in the applications of a wide range of infertility settings.
Guimin Hao, Ai-Min Yang
exaly +4 more sources
Letrozole 2.5 mg Shows Higher Endometrial Thickness Compared to 5 mg Letrozole in Ovulation Induction [PDF]
Indonesian Journal of Obstetrics and Gynecology, 2012 Objective: To compare the effects of ovulation induction with 2.5 mg letrozole to 5 mg letrozole by the number of mature follicles, endometrial morphology and endometrium thickness during the late follicular phase in infertility patient who successfully ...
Anita Tobing
doaj +2 more sources
Current evidence supporting "letrozole" for ovulation induction
Journal of Human Reproductive Sciences, 2013 Aromatase inhibitor "letrozole" was first introduced as a potential ovulation induction (OI) drug almost a decade back. Large number of studies has been published using letrozole for OI: In polycystic ovary syndrome (PCOS) women, clomiphene citrate (CC ...
Sujata Kar
doaj +2 more sources
Middle East Fertility Society Journal, 2016 Objective: To evaluate the efficacy of letrozole in the endometrial preparation of vitrified–warmed embryo transfer cycles and to compare it to the hormonal preparation with estradiol valerate and progesterone study.
Hoda Sibai +2 more
doaj +2 more sources
Middle East Fertility Society Journal, 2018 Background: Letrozole is as effective as clomiphene citrate for induction of ovulation in patients with PCOS. Adequate endometrial development is required for pregnancy to occur, and pregnancy rates were found to be higher when the endometrium reached at
Amr Abd Almohsen Alnemr +3 more
doaj +2 more sources
Randomized interventional clinical trial to estimate the efficacy of clomiphene citrate versus letrozole in induction of ovulation in infertility [PDF]
New Indian Journal of OBGYN, 2022 Background and objectives: Anovulation accounts for 30-40% of female infertility. The treatment of choice is by ovulation induction. This study is to estimate effectiveness of clomiphene citrate versus letrozole in ovulation induction.
Yogindra Kumar Manohar Kabadi +1 more
doaj +1 more source
Maternal aromatase inhibition via letrozole altered RFamide-related peptide-3 and gonadotropin-releasing hormone expression in pubertal female rats [PDF]
Iranian Journal of Basic Medical Sciences, 2022 Objective(s): Despite prevalence of polycystic ovary syndrome (PCOS) among childbearing women and development of many animal models for this syndrome, information on its etiology is still scarce.
Zahra Shaaban +4 more
doaj +1 more source
Journal of Industrial Textiles, 2022 Poloxamer188 composite poly L-lactic acid (PLLA) electrospun fibrous nonwovens (EFNW) were prepared by simple letrozole-poloxamer188-PLLA co-solution electrospinning and used as subcutaneous implants to sustained release letrozole.
Hao Wang +5 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundCyclin-dependent kinase 4/6 inhibitors are a standard treatment for patients with hormone receptor−positive (HR+)/human epidermal growth factor receptor 2−negative (HER2−) metastatic breast cancer (MBC).
Adam Brufsky +4 more
doaj +1 more source
Breast, 2023 Background: Palbociclib, the first available cyclin-dependent kinase 4/6 inhibitor, plus endocrine therapy is approved for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) metastatic breast cancer (MBC).
Hope S. Rugo +5 more
doaj +1 more source